Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Navio MD vs RxSaludable

Navio MD
Graded #112

Higher grade

vs+6.599999999999994
RxSaludable
Graded #259

Lower grade

The verdict

Navio MD takes it — 69.8/100 to 63.2/100.

Navio MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NavioMD offers compounded tirzepatide ($247/mo) plus brand-name Ozempic ($1,199/mo) and Mounjaro ($1,249/mo).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNavio MD +6
57
51
Dose & formulationEven
77
77
Clinical oversightNavio MD +5
87
82
Labs & monitoringNavio MD +1
54
53
FulfillmentNavio MD +9
85
76
Contract termsNavio MD +35
55
20
Navio MD · left barRxSaludable · right bar

The numbers

MetricNavio MDRxSaludable
WeighScore69.8/10063.2/100
GradeCC
Scorecard rank#112#259
Semaglutide$345/mo (starting dose, brand-name)$179/mo (compounded)
Tirzepatide$189/mo (starting dose, compounded)$269/mo (compounded)
Coverage48 statesCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
Navio MD

Graded #112 · C

Strengths

  • LegitScript verified with board-certified providers and US-licensed pharmacies
  • Both compounded and brand-name options
  • 48-state coverage
  • Hours 9am–10pm EST Mon–Sun
  • Transparent tiered pricing: you only pay for your current dose

Where it loses points

  • Not available in Alabama and Mississippi
  • Compounded option is tirzepatide only — no compounded semaglutide listed
  • Also offers women's HRT (broader platform)
  • Pricing is tiered by dose ('as low as'); the entry prices climb as your dose increases
RxSaludable

Graded #259 · C

Strengths

  • Spanish-language platform with Spanish-speaking, U.S.-licensed providers — a genuine gap in GLP-1 telehealth
  • Compounded semaglutide $99 first month ($179/mo after) and tirzepatide $189 first month; same price at every dose, no membership fee
  • LegitScript-certified (#50274281); free expedited shipping; named obesity-medicine physicians
  • Same-day doctor visits, 24/7 support, FSA/HSA eligible, cancel anytime

Where it loses points

  • Ongoing prices ($179-289/mo) are mid-range once the first-month intro ends
  • Doesn't name its compounding pharmacy partners (generic 'certified pharmacies')
  • No legal entity name or explicit state-coverage list published on the site
  • Compounded GLP-1s are not FDA-approved (the site discloses this)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard